Technology
Health
Biotechnology
Enanta
$83.439876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$83.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.71 (2.09%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Enanta and other stocks, options, ETFs, and crypto commission-free!
About ENTA
Enanta Pharmaceuticals, Inc. Common Stock, also called Enanta, is a research and development-focused biotechnology company. Read More It engages in the research and development of molecule drugs for the treatment of viral infections and liver diseases. Its brands include Mavyret and Viekira Pak. The company was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
CEO
Employees
113
Headquarters
Watertown, Massachusetts
Founded
1995
Market Cap
1.61B
Price-Earnings Ratio
21.98
Dividend Yield
0.00
Average Volume
164.28K
High Today
$83.71
Low Today
$81.29
Open Price
$81.73
Volume
125.85K
52 Week High
$126.97
52 Week Low
$64.09
Collections
Technology
Health
Biotechnology
Research And Development
2013 IPO
US
North America
Price Paid on Robinhood
3% Higher
Right Now
52 Week Low
$64.09
Average Price Paid
$80.69
52 Week High
$126.97
Analyst Ratings
43%
of 7 ratings
Buy
43%
Hold
57%
Sell
0%
ENTA Earnings
-$0.06
$0.45
$0.96
$1.47
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Available Aug 6, After Hours